AbCellera Biologics Inc.

NASDAQ: ABCL · Real-Time Price · USD
4.58
0.08 (1.78%)
At close: Aug 15, 2025, 3:59 PM
4.61
0.66%
After-hours: Aug 15, 2025, 07:54 PM EDT

AbCellera Biologics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
156.32M 133.32M 386.54M 476.14M
Short-Term Investments
469.29M 627.26M 499.95M 246.84M
Long-Term Investments
82.3M 65.94M 72.52M 50.31M
Other Long-Term Assets
96.54M 94.24M 41.03M 23.23M
Receivables
92.13M 64.38M 38.59M 160.58M
Inventory
n/a 1.11M 1.53M 1.67M
Other Current Assets
33.63M 45.91M 89.82M 39.28M
Total Current Assets
751.37M 871.99M 1.03B 929.8M
Property-Plant & Equipment
340.43M 287.7M 217.25M 111.62M
Goodwill & Intangibles
89.92M 168.23M 179.31M 196.2M
Total Long-Term Assets
609.18M 616.11M 515.42M 388.77M
Total Assets
1.36B 1.49B 1.54B 1.32B
Account Payables
34.35M 25.51M 14.83M 14.92M
Deferred Revenue
21.18M 18.96M 21.61M 7.54M
Short-Term Debt
n/a n/a n/a n/a
Other Current Liabilities
8.09M 60.68M 69.84M 54.85M
Total Current Liabilities
76.61M 119.01M 118.32M 120.68M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
1.47M 10.82M 19.14M 37.62M
Total Long-Term Liabilities
227.86M 216.76M 189.31M 172.16M
Total Liabilities
304.47M 335.78M 307.63M 292.84M
Total Debt
65.36M 77.38M 82.26M 40.06M
Common Stock
777.17M 753.2M 734.37M 722.43M
Retained Earnings
116.93M 279.79M 426.19M 267.67M
Comprehensive Income
-4.38M -1.72M -1.39M 280K
Shareholders Equity
1.06B 1.15B 1.23B 1.03B
Total Investments
551.59M 693.2M 572.47M 297.15M